시장보고서

상품코드

1510743

아시아태평양의 경피 약물 전달 시스템 : 지역별 분석 - 유형별, 용도별, 유통 채널별 예측(2030년)

Asia Pacific Transdermal Drug Delivery System Market Forecast to 2030 - Regional Analysis - by Type, Application, and Distribution Channel

발행일: 2024년 05월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 112 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

아시아태평양의 경피 약물 전달 시스템 시장은 2022년 90억 2,989만 달러에서 2030년에는 128억 2,077만 달러로 성장할 것으로 예측됩니다. 예측기간 동안 복합 연간 성장률(CAGR)은 4.5%로 추정됩니다.

스마트 패치와 3D 인쇄 패치의 진보가 아시아태평양의 경피 약물 전달 시스템 시장에 박차를 가한다.

경피 약물 투여 경로는 신규하고 지속적인 약물 전달의 신뢰할 수있는 수단 중 하나입니다. 이 부문에서 중요한 연구가 이루어지고, 이 형태의 약물전달에 대한 연구자의 관심이 높아지고 있기 때문에 향후, 많은 경피 패치가 시장에 등장할 것으로 예상됩니다. 경피 패치는 니코틴, 펜타닐, 니트로글리세린, 클로니딘과 같은 약물을 전달하고 다양한 병리를 치료하는 데 사용됩니다. 최근, 이러한 패치는 다양한 용도로 생물학적 제제를 전달하기 위해 연구되고 있습니다. 스마트 패치는 환자의 상태를 모니터링하고 그에 따라 약물전달을 조정하는 센서 및 기타 기술을 갖추고 있습니다. 2023년 1월 Swansea University의 수석 과학자들은 마이크로니들 기술을 이용하여 파킨슨병과 알츠하이머병과 같은 신경퇴행성 질환의 염증성 바이오마커를 검출하는 새로운 스마트 패치를 개발했습니다. 이 스마트 패치는 낮은 침습으로 피부 장벽을 관통하도록 설계된 다수의 마이크로 바늘로 구성되며, 이후 임상적으로 중요한 바이오마커를 모니터링합니다. 일반 클리닉이나 집에서의 POC(Point of Care) 진단을 위해 자기 투여가 가능합니다. 이 혁신적인 조사는 신경 퇴행성 질환의 조기 발견을 크게 변화시킬 수 있습니다.

피부 외용 3D 프린팅 제품 : 2021년 11월에 National Library of Medicine에 게재된 「From Personalized Dressings to Drug Delivery」에 의하면, 피부 표면에 적합하는 개인화된 3D 프린팅 패치는 아세틸헥사펩티드 3(AHP - 3) 배달에 사용할 수 있습니다. 본 조사에서는 폴리에틸렌글리콜디아크릴레이트(PEGDA)와 비닐피롤리돈(VP)의 2유형의 액체 단량체를 다른 비율로 사용하여 최종 중합체의 기계적 강도, 중합 속도, 팽윤 속도를 개선하였습니다. 수지에 대한 최적의 약물 담지는 AHP - 3가 제조 공정을 통해 안정적이고 최종 중합체의 물성에 영향을 미치지 않음을 보여주었습니다. 3D 스캔 안면 모델을 사용하여 개인화된 패치를 컴퓨터 지원 설계 소프트웨어로 설계하고 디지털 광 가공 3D 프린터를 사용하여 최적화 된 수지로 제작했습니다. 제조된 경피 패치의 시험관내 특성화는 인간의 시체 피부에 침투하는 능력을 나타내며, 압축이 더해도 무손상으로 남아 있음을 확인하였습니다.

따라서 3D 프린팅 기술과 스마트 패치의 채택은 향후 몇 년동안 경피 약물 전달 시스템 시장에 기회를 제공 할 가능성이 높습니다.

아시아태평양의 경피 약물 전달 시스템 시장 개요

아시아태평양의 경피 약물 전달 시스템 시장은 중국, 일본, 인도, 호주, 한국 및 기타 아시아태평양의으로 구분됩니다. 고령화 인구 증가, 심혈관 질환 유병률 증가, 비침습 의료기기에 대한 수요 증가로 중국, 인도, 호주 등 국가에서 시장의 급성장이 예상되고 있습니다. 아시아태평양의에서는 중국이 경피 약물 전달 시스템의 최대 시장입니다. 중국에서의 경피 약물 전달 시스템 시장의 성장은 주로 이 나라에서의 기술 성장, 통증 관리를 위한 경피 패치 및 반고형 제품을 개발하는 시장 진출기업 증가 때문입니다.

또한 지난 몇 년동안 중국 기업은 경피 약물 전달 시스템 업계에서 사업을 확대하기 위해 제품 상시 및 승인, 인수, 제휴 및 합병을 실시했습니다. 예를 들어, 2022년 1월에 Suzhou Reveda Medical Co., Ltd.(REVEDA)는 Hybio Pharmaceutical Co., Ltd. 니들 부문으로 제휴한다고 발표했습니다. 합작회사의 60%는 REVEDA Medical, 40%는 Hybio Pharmaceutical이 소유하고 있습니다. 게다가 2021년 9월 영국의 의약품,의료제품규제청은 알츠하이머병에 따른 경도에서 중등도의 치매의 치료로서 Luye Pharma Group의 혁신적인 제제인 리바스티그민 경피흡수형 패치(Rivastigmine) Multi - Day Transdermal Patch : 리바스티그민 MD) 판매 승인을 승인했습니다. 이미 유럽의연합(EU) 회원국의 몇 개국이 동제의 판매 승인을 취득하고 있습니다. 이와 같이 위의 요인으로부터 이 나라의 경피흡수형 약물 전달시스템 시장은 향후 수년간 수요를 끌어올릴 것으로 예상됩니다.

아시아태평양의 경피 약물 전달 시스템 시장 수익과 예측(-2030년)(금액)

아시아태평양의 경피 약물 전달 시스템 시장 세분화

아시아태평양의 경피 약물 전달 시스템 시장은 유형, 용도, 유통 채널, 국가로 구분됩니다.

유형별로 아시아태평양의 경피 약물 전달 시스템 시장은 경피 패치, 경피 젤, 경피 스프레이 등으로 구분됩니다. 2022년 아시아태평양의 경피 약물 전달 시스템 시장에서는 경피 겔 부문이 가장 큰 점유율을 차지합니다. 경피 패치는 또한 약물 접착 패치, 매트릭스 패치, 저장소 막 패치, 증기 패치로 세분화됩니다.

용도별로 아시아태평양의 경피 약물 전달 시스템 시장은 심혈관 질환, 중추 신경 장애, 통증 관리, 호르몬 용도 및 기타 용도로 분류됩니다. 통증 관리 부문은 2022년 아시아태평양의 경피 약물 전달 시스템 시장에서 가장 큰 점유율을 차지했습니다. 통증 관리는 또한 오피오이드 및 비 오피오이드로 하위 부문화됩니다. 호르몬 애플리케이션은 또한 경피 에스트로겐 및 프로게스테론 치료와 테스토스테론 보충으로 세분화됩니다.

유통 채널별로 아시아태평양의 경피 약물 전달 시스템 시장은 병원 약국, 소매 약국, 온라인 약국 등으로 구분됩니다. 2022년 아시아태평양의 경피 약물 전달 시스템 시장에서는 병원 약국 부문이 가장 큰 점유율을 차지합니다.

국가별로 볼 때 아시아태평양의 경피 약물 전달 시스템 시장은 중국, 일본, 인도, 호주, 한국 및 기타 아시아태평양의으로 분류됩니다. 2022년 아시아태평양의 경피 약물 전달 시스템 시장은 중국이 독점하고 있습니다.

Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Luye Pharma Group Ltd, Novartis AG, Viatris Inc는 아시아태평양의 경피 약물 전달 시스템 시장에서 사업을 전개하고 있는 대기업입니다.

시장 성장 촉진요인
- 만성질환의 유병률 증가
- 비침습 약물전달 디바이스에 대한 수요 증가
- 약제의 자기 투여에 대한 높은 수요
시장 성장 억제요인
- 경피 약물 전달 시스템의 부작용과 리콜
시장 기회
- 스마트 패치와 3D 프린팅 패치의 진보
향후의 동향
- 제조업체에 의한 전략적 이니셔티브
영향 분석

제5장 경피 약물전달 시스템 시장 : 아시아태평양의 시장 분석

아시아태평양 경피 약물전달 시스템 시장 수익 예측기간 동안

제6장 아시아태평양의 경피 약물 전달 시스템 시장 : 유형별 수익과 예측(-2030년)

소개
아시아태평양 경피 약물전달 시스템 시장(2022년 및 2030년) : 유형별 매출액 점유율(%)
경피 패치
경피 겔
경피 스프레이
기타

제7장 아시아태평양의 경피 약물 전달 시스템 시장 : 용도별 수익과 예측(-2030년)

소개
아시아태평양 경피 약물전달 시스템 시장(2022년 및 2030년) : 용도별 매출액 점유율(%)
심혈관 질환
중추 신경계 질환
통증 관리
호르몬 용도
기타

제8장 아시아태평양의 경피 약물 전달 시스템 시장 : 수익과 예측(-2030년) 유통 채널별

소개
아시아태평양 경피 약물 전달 시스템 시장(2022년 및 2030년) : 유통 채널별 매출 점유율(%)
병원 약국
소매 약국
온라인 약국
기타

제9장 아시아태평양의 경피 약물 전달 시스템 시장 : 수익과 예측(-2030년) 국가별 분석

중국
일본
인도
호주
한국
기타 아시아태평양

제10장 경피 약물전달 시스템 시장 업계 정세

소개
경피 약물 전달 시스템 시장의 성장 전략
무기적 성장 전략
유기적 성장 전략

제11장 기업 프로파일

Novartis AG
Johnson & Johnson
GSK Plc
Viatris Inc
Boehringer Ingelheim International GmbH
Hisamitsu Pharmaceutical Co Inc
Luye Pharma Group Ltd

제12장 부록

BJH 24.07.18

The Asia Pacific transdermal drug delivery system market is expected to grow from US$ 9,029.89 million in 2022 to US$ 12,820.77 million by 2030. It is estimated to register a CAGR of 4.5% from 2022 to 2030.

Advancements in Smart Patches and 3D-Printed Patches Fuel Asia Pacific Transdermal Drug Delivery System Market

A transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being conducted in this field and the increasing interest of researchers in this form of drug delivery, a large number of transdermal patches are likely to reach the marketplace in the future. Transdermal patches are used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various medical conditions. Recently, these patches have been explored to deliver biologics in various applications. Smart patches are equipped with sensors and other technologies to monitor patient conditions and adjust drug delivery accordingly. In January 2023, a lead scientist at Swansea University developed a new smart patch to detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson's and Alzheimer's using the microneedle technology. These smart patches comprise numerous microneedles designed to penetrate the skin barrier in a minimally invasive manner, followed by monitoring the biomarkers of clinical significance. They can be self-administered for point-of-care diagnosis at general practices or at home. This innovative research can potentially change the landscape of early neurodegenerative disease detection.

According to an article titled "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery," published in the National Library of Medicine in November 2021, personalized 3D-printed patches that conform to the skin surface can be used for acetyl-hexapeptide 3 (AHP-3) delivery. In this study, two liquid monomers-polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)-were used in different proportions to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software, and it was fabricated in optimized resin using a digital light processing 3D printer. The in-vitro characterization of prepared transdermal patches has shown their ability to penetrate human cadaver skin, further remaining intact upon compression. "3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery" is the first study demonstrating personalized patches made using photopolymers, and it has introduced a novel approach to improve the transdermal delivery of drugs for effective wrinkle management.

Thus, the adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market in the coming years.

Asia Pacific Transdermal Drug Delivery System Market Overview

The Asia Pacific transdermal drug delivery systems market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth is expected to be fastest in countries such as China, India, and Australia due to growing aging population, increasing prevalence of cardiovascular diseases, and increasing demand for non-invasive medical devices. In Asia Pacific, China is the largest market of transdermal drug delivery systems. The growth of the transdermal drug delivery system market in China is primarily attributed to the growing technology in the country, increasing developments by the market players to develop transdermal patches and semisolid products for pain management.

Also, in the last few years, companies in China are undergoing product launches and approvals, acquisitions, partnerships, and mergers to expand their business in the transdermal drug delivery systems industry. For instance, in January 2022, Suzhou Reveda Medical Co., Ltd. (REVEDA) announced that it partnered with Hybio Pharmaceutical Co., Ltd. (Hybio Pharmaceutical) to set up a joint venture for drug-device combination products and team up in the field of polypeptide micro-needles for transdermal delivery. 60% of the joint venture will be owned by REVEDA Medical and 40% by Hybio Pharmaceutical. Furthermore, in September 2021, the UK's Medicines and Healthcare Products Regulatory Agency granted marketing approval for Luye Pharma Group's innovative formulation Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD) for the treatment of mild to moderate dementia associated with Alzheimer's disease. Several European Union nations already have marketing authorization for the medicine. Thus, owing to the abovementioned factors, the market is expected to propel the demand for transdermal drug delivery systems in this country in the upcoming years.

Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Transdermal Drug Delivery System Market Segmentation

The Asia Pacific transdermal drug delivery system market is segmented into type, application, distribution channel, and country.

Based on type, the Asia Pacific transdermal drug delivery system market is segmented into transdermal patches, transdermal gel, transdermal sprays, and others. The transdermal gel segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022. The transdermal patches is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and vapor patches.

In terms of application, the Asia Pacific transdermal drug delivery system market is categorized into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The pain management segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022. The pain management is further sub segmented into opioid and non-opioid. The hormonal applications is further sub segmented into transdermal estrogen & progesterone therapy and testosterone replacement.

By distribution channel, the Asia Pacific transdermal drug delivery system market is segmented into hospitals pharmacies, retail pharmacies, online pharmacies, and others. The hospitals pharmacies segment held the largest share of the Asia Pacific transdermal drug delivery system market in 2022.

Based on country, the Asia Pacific transdermal drug delivery system market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific transdermal drug delivery system market in 2022.

Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Luye Pharma Group Ltd, Novartis AG, and Viatris Inc are some of the leading companies operating in the Asia Pacific transdermal drug delivery system market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Transdermal Drug Delivery System Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Chronic Diseases
- 4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
- 4.1.3 High Demand for Self-Administration of Drugs
4.2 Market Restraints
- 4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
4.3 Market Opportunities
- 4.3.1 Advancements in Smart Patches and 3D-Printed Patches
4.4 Future Trends
- 4.4.1 Strategic Initiatives by Manufacturers
4.5 Impact Analysis

5. Transdermal Drug Delivery System Market - Asia Pacific Market Analysis

5.1 Asia Pacific Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Type

6.1 Overview
6.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Transdermal Patches
- 6.3.1 Overview
- 6.3.2 Transdermal Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.1 Drug-in-Adhesive Patches
    - 6.3.2.1.1 Overview
    - 6.3.2.1.2 Drug-in-Adhesive Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.2 Matrix Patches
    - 6.3.2.2.1 Overview
    - 6.3.2.2.2 Matrix Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.3 Reservoir Membrane Patches
    - 6.3.2.3.1 Overview
    - 6.3.2.3.2 Reservoir Membrane Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.4 Vapor Patches
    - 6.3.2.4.1 Overview
    - 6.3.2.4.2 Vapor Patches: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Transdermal Gels
- 6.4.1 Overview
- 6.4.2 Transdermal Gels: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Transdermal Sprays
- 6.5.1 Overview
- 6.5.2 Transdermal Sprays: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cardiovascular Diseases
- 7.3.1 Overview
- 7.3.2 Cardiovascular Diseases: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Central Nervous System Disorders
- 7.4.1 Overview
- 7.4.2 Central Nervous System Disorders: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Pain Management
- 7.5.1 Overview
- 7.5.2 Pain Management: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.5.2.1 Opioid
    - 7.5.2.1.1 Overview
    - 7.5.2.1.2 Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.5.2.2 Non-Opioid
    - 7.5.2.2.1 Overview
    - 7.5.2.2.2 Non-Opioid: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hormonal Applications
- 7.6.1 Overview
- 7.6.2 Hormonal Applications: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.6.2.1 Transdermal Estrogen & Progesterone Therapy
    - 7.6.2.1.1 Overview
    - 7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.6.2.2 Testosterone Replacement
    - 7.6.2.2.1 Overview
    - 7.6.2.2.2 Testosterone Replacement: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Other Application
- 7.7.1 Overview
- 7.7.2 Other Application: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview
8.2 Asia Pacific Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Hospital Pharmacies
- 8.3.1 Overview
- 8.3.2 Hospital Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Retail Pharmacies
- 8.4.1 Overview
- 8.4.2 Retail Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
- 8.5.1 Overview
- 8.5.2 Online Pharmacies: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Asia Pacific Transdermal Drug Delivery System Market
- 9.1.1 Asia Pacific Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  - 9.1.1.1 China: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.1.1 Overview
    - 9.1.1.1.2 China: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.1.3 China: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
    - 9.1.1.1.3.1 China: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
    - 9.1.1.1.4 China: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
    - 9.1.1.1.4.1 China: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
    - 9.1.1.1.4.2 China: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    - 9.1.1.1.5 China: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 9.1.1.2 Japan: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.2.1 Overview
    - 9.1.1.2.2 Japan: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.2.3 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
    - 9.1.1.2.3.1 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
    - 9.1.1.2.4 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
    - 9.1.1.2.4.1 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
    - 9.1.1.2.4.2 Japan: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    - 9.1.1.2.5 Japan: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 9.1.1.3 India: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.3.1 Overview
    - 9.1.1.3.2 India: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.3.3 India: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
    - 9.1.1.3.3.1 India: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
    - 9.1.1.3.4 India: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
    - 9.1.1.3.4.1 India: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
    - 9.1.1.3.4.2 India: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    - 9.1.1.3.5 India: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 9.1.1.4 Australia: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.4.1 Overview
    - 9.1.1.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.4.3 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
    - 9.1.1.4.3.1 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
    - 9.1.1.4.4 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
    - 9.1.1.4.4.1 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
    - 9.1.1.4.4.2 Australia: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    - 9.1.1.4.5 Australia: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 9.1.1.5 South Korea: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.5.1 Overview
    - 9.1.1.5.2 South Korea: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.5.3 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
    - 9.1.1.5.3.1 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
    - 9.1.1.5.4 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
    - 9.1.1.5.4.1 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
    - 9.1.1.5.4.2 South Korea: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    - 9.1.1.5.5 South Korea: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
  - 9.1.1.6 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.6.1 Overview
    - 9.1.1.6.2 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.6.3 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
    - 9.1.1.6.3.1 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
    - 9.1.1.6.4 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
    - 9.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
    - 9.1.1.6.4.2 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
    - 9.1.1.6.5 Rest of Asia Pacific: Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Transdermal Drug Delivery System Market Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Transdermal Drug Delivery System Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Novartis AG
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Johnson & Johnson
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 GSK Plc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Viatris Inc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Boehringer Ingelheim International GmbH
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Hisamitsu Pharmaceutical Co Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Luye Pharma Group Ltd
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments

12. Appendix

12.1 About Us
12.2 Glossary of Terms